The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global cell-based assay market was valued at US$ 18.9 Billion in 2021.
We expect the global cell-based assay market to exhibit a CAGR of 8.78% during 2022-2027.
The widespread adoption of cell-based assay for high throughput screening methods, including
toxicity studies, drug screening, in vitro testing, etc., is primarily driving the global cell-based assay
The sudden outbreak of the COVID-19 pandemic has led to the increasing application of cell-based
assay experiment to study and understand the nature of coronavirus infection and develop vaccines,
drugs, and testing kits for its treatment.
Based on the product and services, the global cell-based assay market has been segmented into
consumables, instruments, services, and software. Among these, consumables represent the largest
Based on the application, the global cell-based assay market can be bifurcated into drug discovery,
basic research, ADME studies, predictive toxicology, and others. Currently, drug discovery accounts
for the majority of the total market share.
On a regional level, the market has been classified into North America, Europe, Asia Pacific, Middle
East and Africa, and Latin America, where North America currently dominates the global market.
Some of the major players in the global cell-based assay market include Becton Dickinson and
Company, GE Healthcare Biopharma (Danaher Corporation), Thermo Fisher Scientific Inc., Merck
Group, Perkinelmer Inc., Charles River Laboratories Inc., Lonza Group Ltd., Cell Signaling Technology
Inc., Promega Corporation, Cell Biolabs Inc., Eurofins DiscoverX Corporation, Bio-Rad Laboratories
Inc., Corning Inc., and F. Hoffmann-La Roche AG (Roche Holding AG).
Swine Healthcare Market by Product (Diagnostic Tests, Therapeutics), Disease (Exudative Dermatitis, Coccidiosis, Respiratory Diseases, Swine Dysentery, Porcine Parvovirus, and Others), Route of Administration (Injectable, Oral), Distribution Channel (Veterinary Hospitals, Retail Pharmacy, Online Pharmacy), and Region 2023-2028
Epilepsy Drugs Market by Generation Type (First Generation Drugs, Second Generation Drugs, Third Generation Drugs), Anti-Epileptics Drugs Type (Narrow-Spectrum AEDs, Broad-Spectrum AEDs), Distribution Channel (Hospital Pharmacy, Pharmacy Stores, and Others), and Region 2023-2028
Congestive Heart Failure Drugs Market by Drug Class (ACE Inhibitors, Angiotensin 2 Receptor Blockers, Beta Blockers, Diuretics, Aldosterone Antagonists, Inotropes, and Others), Route of Administration (Oral, Intravenous), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Region 2023-2028
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at